Call us now0755-8668-0658 E-mailinfo@immuclin.com

27

09

Technological innovation, gathered together-Shenzhen Yishi Kangning appeared at the 2017 Shenzhen International Biological/Life Health Industry Exhibition
Article Author:admin Category:Coperate News Reading:730

On September 21, 2017, the 2017 Shenzhen International Biology/Life and Health Industry Exhibition (hereinafter referred to as "Bio Expo") officially kicked off at the Shenzhen Convention and Exhibition Center. Wang Weizhong, Member of the Standing Committee of the Guangdong Provincial Party Committee and Secretary of the Shenzhen Municipal Party Committee, Guo Yonghang, Member of the Standing Committee of the Shenzhen Municipal Party Committee and Secretary-General, and Ai Xuefeng, Deputy Mayor of Shenzhen, attended the opening ceremony and visited the exhibition hall for on-site inspection and guidance. Shenzhen Yishi Kangning Biotechnology Co., Ltd. is fortunate to be invited to participate in this exhibition.


Comrade Wang Weizhong, Secretary of the Shenzhen Municipal Party Committee, visited the exhibition site to guide the work

With the theme of "Developing Wisdom and Health, Creating New Industry Engines", this year's Biological Exhibition will gather the resources of domestic and foreign biological and life and health industries, help promote the development of the biological industry, and accelerate the implementation of innovative development strategies. Enhance the professional influence of the biological and life health industries. At the same time, this exhibition attracted more than a hundred international high-quality exhibitors to showcase their latest scientific and technological achievements, new products and new technologies.

exhibition site

During the exhibition, ISKCON demonstrated the company's ACTL innovative technology and latest research results to the exhibitors. The audiences who came to the consultation were carefully explained and effective cancer-related knowledge popularization, and the company's ACTL targeted anti-tumor cell immune technology research and development status and clinical application knowledge were exchanged and learned with relevant personnel.

The staff of ISKCON is explaining to the audience on the spot (Picture 1)


The staff of ISKCON is explaining to the audience on the spot (Picture 2)


In this exhibition, in view of the company's continuous innovation of ACTL technology, the company's project was awarded the honor of "2017 Bio/Life Health Industry Innovation Achievement Gold Award". This is another affirmation after winning the "2014 Gold Award for Bio/Life and Health Industry Innovation Achievement" and "2014 Silver Award for Bio/Life and Health Industry Innovation Achievement" in 2014!

2017 Gold Award for Innovation Achievement in Bio/Life and Health Industry


In 2017, the representative of ISKCON took the stage to receive the award (second from right)


ISKCON was awarded one gold and one silver in 2014


Each honor is an affirmation of the ISKCONN team, and at the same time, it is also our motivation to move forward. As a benchmarking company for innovative biological enterprises in Shenzhen, Ishikoning will continue to improve its R&D capabilities, promote the transformation of more innovative achievements into clinical practice, and provide the public with better life and health protection. Further strengthen the technical exchange and development of biomedicine at home and abroad, and actively contribute to the development of Shenzhen's biological/life health industry.

Keyword:
Share: